Attorney Wire Briefing: July 17, 2026
Includes Paramount merger litigation, revived acetaminophen mass torts, Trump’s dismissed IRS suit, and CVS’s insulin settlement.
Good morning – it’s Friday, July 17, 2026.
Here are six key legal developments we’re following.
Estimated read time: 4 minutes
Lead Story
12 States Sue to Block Paramount’s $111 Billion Warner Bros. Discovery Deal
What happened: California and 11 other states sued to block Paramount’s $111 billion acquisition of Warner Bros. Discovery, alleging that the deal would violate Section 7 of the Clayton Act by raising prices, reducing content quality and output, and weakening competition in film and basic cable distribution.
Why it matters: The suit follows the Justice Department’s decision not to challenge the transaction, underscoring that states may independently enforce the Clayton Act.
Implication: Counsel should account for state enforcement when evaluating closing risk and timing. Beginning in October, Paramount must pay shareholders $650 million for each quarter the deal remains pending. The complaint’s focus on widely distributed and top-grossing films highlights the importance of market definition in media-merger litigation.
Read more: New York Times | Complaint
The Docket
Second Circuit Revives More Than 500 Acetaminophen Product Liability Suits
The U.S. Court of Appeals for the Second Circuit reversed a district court’s exclusion of expert testimony on an alleged link between acetaminophen use during pregnancy and autism spectrum disorder or ADHD. The court held the experts reliably applied accepted scientific methods, but did not decide whether acetaminophen causes either condition. The ruling reinstates more than 500 product liability suits against Kenvue and retailers including CVS, Target, Walgreens, and Walmart.
Why it matters: The decision revives a major mass-tort docket and clarifies the Second Circuit’s standard for evaluating disputed expert causation testimony.
…..
Florida Federal Judge Finds No Article III Controversy in Trump’s $10 Billion IRS Suit
The U.S. District Court for the Southern District of Florida dismissed President Donald Trump’s $10 billion suit against the IRS, holding it lacked the adversity required by Article III because Trump and the IRS are both part of the executive branch. The court also barred Trump and his family from describing a Justice Department tax-audit agreement as a court-approved settlement and referred attorneys, including Todd Blanche and Alejandro Brito, for possible disciplinary proceedings.
Why it matters: The ruling reinforces Article III’s case-or-controversy requirement and highlights professional-responsibility risks when parties seek judicial approval without a genuine dispute.
Read more: New York Times | Order
…..
CVS Caremark Settles FTC Insulin Case, Agrees to Credit TrumpRx Purchases Toward Deductibles
CVS Caremark settled Federal Trade Commission allegations that its rebate practices increased insulin costs. The agreement caps patients’ out-of-pocket insulin costs at $25 per month, requires an alternative payment model, and gives qualifying independent pharmacies the option of reimbursement based on acquisition cost plus a fee. Caremark also must count eligible TrumpRx purchases toward deductibles under certain health plans once regulations take effect.
Why it matters: The settlement reduces reliance on rebate-based pricing and may require health plans to update claims administration and deductible tracking.
Read more: Reuters | Decision and Order
…..
Justice Department Subpoenas 13 Law Firms, Seeks Depositions of Firm Leaders
The Justice Department subpoenaed 13 major law firms for communications with President Donald Trump’s personal lawyer, Boris Epshteyn, and records concerning agreements between nine firms and the White House. The department also seeks depositions of a senior leader from each firm. The subpoenas arise from an American Bar Association lawsuit challenging the administration’s actions against law firms.
Why it matters: The dispute raises questions about third-party discovery, privilege, and burden. The firms must preserve records, conduct privilege reviews, and decide whether to comply, negotiate the subpoenas’ scope, or seek protective relief.
Read more: New York Times | Motion to Compel
…..
FTC Backs Ohio Proposal to End ABA’s Exclusive Accreditation Role
The Federal Trade Commission endorsed a proposed Ohio Supreme Court rule ending the American Bar Association’s exclusive role in determining whether an applicant’s legal education satisfies bar-admission requirements. The FTC argued that relying on a single accreditor restricts entry into the profession and increases education and legal-service costs. The proposal would recognize legal education accredited under alternative standards.
Why it matters: The proposal could reshape bar-admission eligibility, legal education, and attorney mobility while adding federal antitrust support to similar state efforts.
Read more: Bloomberg Law | Letter (Public Comment)
Partner Signal
Privacy and Cybersecurity Top List of Corporate Legal Talent Gaps
Privacy and cybersecurity were the legal specialties most affected by talent shortages. With lawyer unemployment at 1.0% and recruiting increasingly difficult, companies may rely more heavily on outside counsel.
What We’re Watching
Meta Workers Allege AI-Assisted Layoffs Discriminated Against Employees on Leave
A federal lawsuit alleges Meta used AI-assisted layoff metrics that discriminated against employees on protected leave or with disabilities, violating the Family and Medical Leave Act and federal disability-discrimination laws. Meta denies AI made the termination decisions.
Brought to You by Attorney Credits
Now offering Live CLE Webinars. Serving over 130K attorneys with more than 3 million courses delivered.